Lymphedema Prevention Post Breast Cancer | LeaN On Study Australia
Discover how Flinders University's LeaN On study offers new hope for breast cancer survivors at risk of lymphedema through a digital self-management platform.
No reviews yet. Be the first to rate Richard!
Professor Richard Woodman is Professor in Biostatistics & Epidemiology in the College of Medicine and Public Health at Flinders University. He holds a PhD in Medicine from the University of Western Australia, a Master of Biostatistics from the University of Sydney, a Master of Medical Science in Sport and Exercise Science from the University of Sheffield, and a Bachelor of Science in Maths and Physics from the University of Exeter. His research focuses on the design and analysis of randomised controlled trials and observational studies, biostatistical techniques, the application of AI and machine learning in medicine and healthcare, nutrition, hospital mortality, and pharmacoepidemiology. He has published more than 300 papers in high-ranking journals, with over 11,000 citations, including more than 150 peer-reviewed articles in the past five years. He has contributed to externally funded grants totalling AUD$21 million, including AUD$12.8 million since 2018.
Professor Woodman has served as past president and council member of the Statistical Society of Australia (South Australia branch), as a statistical editor for the British Journal of Nutrition and the European Journal of Clinical Nutrition, and as a member of editorial boards for Therapeutic Advances in Drug Safety and Clinical Science. He is a member of the ACSQHC Patient Safety Reporting Committee and has supervised 11 PhD students, two masters students, three honours students, and five MD students to completion, with additional current supervisions. He has also contributed expert commentary on statistical methods such as Bland-Altman analysis, propensity score matching, and least-squares regression. His professional email is richard.woodman@flinders.edu.au.
Discover how Flinders University's LeaN On study offers new hope for breast cancer survivors at risk of lymphedema through a digital self-management platform.